A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Sponsor: Merck Sharp & Dohme LLC
Germantown, TN · +62 more sites
6 recruiting prostate cancer studies with a site in Germantown, TN.
Sponsor: Merck Sharp & Dohme LLC
Germantown, TN · +62 more sites
Sponsor: Pfizer
Chattanooga, TN · +124 more sites
Sponsor: Alliance for Clinical Trials in Oncology
Germantown, TN · +746 more sites
Sponsor: Janssen Research & Development, LLC
Germantown, TN · +3 more sites
Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited
Germantown, TN · Nashville, TN · +14 more sites
Sponsor: SWOG Cancer Research Network
Germantown, TN · +173 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.